Disease/Infection News

RSS

Demographic, geographic, and temporal variables associated with C. auris cases in Italy

A recent study reported growing cases of Candida auris in North Italy.

27 Mar 2023

Study reveals new insights into how different countries' research establishments respond to disease

In a new study, researchers examined how a country's number of published 3D protein structures for coronaviruses, including the one responsible for COVID-19, correlated with its economic output and population.

27 Mar 2023

Study adds valuable new information on the treatment of COVID-19

Although steroid treatment for COVID-19 is reportedly beneficial in some cases, details—such as the upper dosing limits and safety of this method—have not yet been clarified.

27 Mar 2023

Monocytes may be a stable reservoir of HIV in patients taking antiretroviral therapy

To develop treatments that may one day entirely rid the body of HIV infection, scientists have long sought to identify all of the places that the virus can hide its genetic code.

27 Mar 2023

Researchers discuss strategic actions to stimulate research on fungal diseases in the context of the WHO fungal pathogens priority list

Researchers in the US and Brazil explored priority fungal pathogens recognized by the WHO.

27 Mar 2023

How can microbiota be used to make wine more health beneficial?

Researchers discussed the use of wine microbiota in enhancing the functional components of wine during production.

27 Mar 2023

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era

Researchers in the United States assessed the risk associated with SARS-CoV-2 reinfection.

27 Mar 2023

Possible pathways of C. auris emergence and the hypothetical role of interspecies transmission

Researchers summarized the current understanding of the emergence and ecologic niches of Candida auris.

27 Mar 2023

Researchers isolate an IgM exhibiting ultrapotent neutralization from a Zika virus-infected pregnant woman

A recent study published in the Cell Press Journal demonstrated that plasma immunoglobulins of isotype M elicited during pregnancy have an exceptional Zika virus-neutralizing potential.

27 Mar 2023

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?

Researchers performed an observational cohort study using the US Department of Veterans Affairs healthcare databases.

27 Mar 2023

Study finds persistent decrease in daily step count among U.S. adults post-pandemic

In a recent study published in JAMA Network Open, researchers in Tennessee investigated whether the coronavirus disease 2019 (COVID-19) pandemic altered daily step counts among individuals participating in All of Us (AOU) research programs.

27 Mar 2023

The vital role of patients and the general public in guiding long-COVID research

In a recent study published in the journal Nature Medicine, researchers in the United Kingdom (UK) emphasized the significance of public and patient involvement (PPI) in scientific studies on long coronavirus disease (COVID).

27 Mar 2023

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

In a recent prospective study published in the Annals of Internal Medicine Journal, researchers in the United States (US) and Spain performed a randomized controlled trial (RCT) across 127 US hospitals between 2021 and 2022.

27 Mar 2023

Curcumin reduces inflammatory responses in post-COVID vaccinated adults

A new study published in the Nutrients Journal highlights the impact of curcumin supplementation on the immune response following the immunization of Coronavirus disease 2019 (COVID-19) survivors with a primary series of monovalent COVID-19 vaccines.

26 Mar 2023

Incidence of tuberculosis reaches 2.5 cases per 100,00 in the U.S.

The United States (US) Centers for Disease Control and Prevention (CDC) has recently released preliminary data on tuberculosis incidence in the US in 2022. The report is published in the Morbidity and Mortality Weekly Report.

26 Mar 2023

Advancements in understanding and treating breast cancer

Researchers describe recent advancements in breast cancer research.

26 Mar 2023

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

The National Institute of Allergy and Infectious Diseases awarded an up to $16 million contract to Tulane University to bring to phase one clinical trial a nasal spray vaccine university researchers invented to thwart antibiotic-resistant Klebsiella pneumoniae, a leading cause of pneumonia.

24 Mar 2023

Disease/Infection News

Demographic, geographic, and temporal variables associated with C. auris cases in Italy

Study reveals new insights into how different countries' research establishments respond to disease

Study adds valuable new information on the treatment of COVID-19

Monocytes may be a stable reservoir of HIV in patients taking antiretroviral therapy

Researchers discuss strategic actions to stimulate research on fungal diseases in the context of the WHO fungal pathogens priority list

How can microbiota be used to make wine more health beneficial?

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era

Possible pathways of C. auris emergence and the hypothetical role of interspecies transmission

Researchers isolate an IgM exhibiting ultrapotent neutralization from a Zika virus-infected pregnant woman

Is nirmatrelvir treatment of SARS-CoV-2 associated with a lower risk of post–COVID-19 condition?

Study finds persistent decrease in daily step count among U.S. adults post-pandemic

The vital role of patients and the general public in guiding long-COVID research

A randomized trial of a blood thinner after severe COVID-19 to prevent clotting events

Curcumin reduces inflammatory responses in post-COVID vaccinated adults

Incidence of tuberculosis reaches 2.5 cases per 100,00 in the U.S.

Advancements in understanding and treating breast cancer

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

Substance use disorders not associated with COVID-19-related mortality

Nasally administered molecule effective in preventing all SARS-CoV-2 variants

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News